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This preliminary study aimed to adapt theDysarthria Impact Profile (DIP) in French and to confirm its relevance for the assessment
of the psychosocial impact of dysarthria in Parkinson’s disease (PD). The DIP scale was administered to 10 people with PD and
10 age-matched control subjects.The DIP psychometric properties were calculated (discriminant validity, internal consistency, and
concurrent validity), notably by using the Voice Handicap Index (VHI) for interscale comparisons. The French version of the DIP
discriminated peoplewith PD from control subjects (𝜒2 test,𝑃 < 0.05). Good internal consistencywas observed in both populations
(Cronbach’s 𝛼 = 0.93 for PD people and 𝛼 = 0.76 for control subjects). The DIP was highly correlated with the VHI (Spearman’s
𝜌 = −0.70, 𝑃 < 0.01), confirming the external validity of the scale. There was no direct relationship between PD speech and quality
of life as assessed by the Parkinson’s Disease Questionnaire-39 (PDQ-39). Our preliminary data suggest that the French version of
the DIP has the potential to make a useful contribution for the assessment and outcome management in acquired dysarthria for
both clinicians and researchers.
1. Introduction
Improving quality of healthcare and encouraging clinicians
to adopt a more holistic approach to the assessment and
treatment of patients were significant contributions of the
International Classification of Functioning Disability and
Health (ICF), promoted by the World Health Organization
(WHO) during the 2001 international conference in Geneva
[1] to the field of speech sciences. Since the adoption of this
framework, considering patients’ personal feelings regarding
physical, psychological, and social domains has received
increasing interest over the last decade. Classical assessment
procedures now aim at including evaluations of quality
of life and well-being in populations with communication
impairments [2]. However, the few tools available for the
investigation of the psychological and social impact of oral
communication deficits mainly focus on voice and speech
production disorders [3–6].
Hypokinetic dysarthria in Parkinson’s disease (PD) is a
motor speech disorder that arises as a consequence of a
neurodegenerative process. Around 70% of people with PD
are affected to some degree by voice and speech impairment
[7], leading one to consider that communication impairment
is highly prevalent and debilitating in this population. Indeed,
people with PD are less likely to participate in conversations,
or to have confidence in social interactions [8]. Several studies
suggest that as PD progression is associated with a growing
discomfort in verbal communication, there is an important
negative alteration to social life [9–11]. Capturing the impact
of dysarthria on the person with PD is not straightforward.
While there are many clinical and instrumental ways to
evaluate dysarthria, the person’s own experience of his/her
communicative limitations has been long neglected. Even if
dedicated self-reporting questionnaires for the assessment
of voice and speech difficulties arising from dysarthria
are available [12–14], scales examining the impact of such
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difficulties on daily-living activities are scarce. To address
this limitation, the Dysarthria Impact Profile (DIP) has
been proposed as an alternative for the assessment of the
psychosocial impact of dysarthria on speakers [15]. Whereas
the gold standard dysarthria questionnaires mainly assess
speech and/or voice parameters (e.g., acoustics, articulation),
the original approach of the DIP is to focus on the impact
of speech deficits’, specifically the psychosocial impact of the
speech disorder on the communicative participation from the
speaker’s perspective.
The term “psychosocial impact” is multidimensional [16,
17], defined as “the psychological and social consequences of
a motor speech disorders with quality of life, subjective well-
being, and societal participation, viewed predominantly as con-
sequence or factors that contribute to psychosocial impact” [2].
The DIP scale was designed using data from in-depth inter-
views with people presenting with non-congenital dysarthria
[18, 19], drawing also from earlier accounts from other
researchers [18, 20–23] and personal accounts of individuals
with dysarthric speech [24–26]. From these data, forty-eight
itemswere drawn up and divided into five specific topic areas:
(1) the effect of dysarthria on me as a speaker, (2) accepting
my dysarthria, (3) how I feel others react to my speech, (4)
how dysarthria affects my communication with others, and
(5) dysarthria relative to other worries and concerns [15].This
scale has been used in studies examining the psychosocial
impact of dysarthria from the speaker’s perspective [23, 27,
28].
The DIP was devised in English and is used with English
speaking populations. The main goal of this study was to
translate the DIP into French and assess its relevance in
French for the description of the psychosocial impact of
dysarthria in PD. We explored the discriminant validity, (i.e.,
the comparison between the PD population scores with the
scores from control subjects); the concurrent validity of the
DIP, by calculating its correlation with other self-reporting
questionnaires that aimed at evaluating associated constructs
of voice handicap and quality of life; and the relationship
between the negative impact of PD speech and negative
quality of life.
2. Material and Methods
2.1. Participants. Ten people with PD (6males and 4 females)
and under medication participated in the study. They were
recruited by a movement disorders’ neurologist (F.V.) at
the Neurology Department of the Aix-en-Provence Hospital
(Centre Hospitalier du Pays d’Aix), where they attended out-
patient clinics.Themean (±SD) age of the participant sample
was 68.6 ± 12.3 years (age range: from 47 to 84 years). The
mean (±SD) disease duration was 4.7±3.6 years (range: from
4 months to 9 years). The selection criteria included patients
diagnosed with idiopathic PD, no cognitive impairment,
no history of hearing impairment, and no previous speech
therapy rehabilitation. The patients recruited underwent an
examination using part III of the Unified Parkinson’s Disease
Rating Scale, UPDRS [29], which assessed the global motor
state of the patients. The mean (±SD) UPDRS III score on
medication was 14.1 ± 7.2. The cognitive state of the patients
was evaluated using either the Mattis Dementia Rating Scale
[30] or the Mini-Mental State Examination [31]. None of the
participants had evidence of any cognitive impairment.
Ten age-matched healthy control subjects (4 males and
6 females) were recruited from the experimenters’ personal
contacts to participate in the study. The mean (±SD) age of
the control groupwas 72.4±3.9 years (age range: from70 to 83
years). None of the control subjects had history of any hearing
or cognitive impairment or other neurologic or psychiatric
diseases. Demographics and characteristics of people with
PD and control participants are summarized in Table 1.
2.2. Assessment Measures. Two valid and reliable assessment
measures (the Voice Handicap Index, VHI, and the Parkin-
son’s Disease Questionnaire, PDQ-39) were used along with
the DIP. All the assessments were administered in one day.
Regarding the people with PD, three participants completed
the scales with the help of an experimenter (A.L.), since they
presented with writing difficulties; the remainder completed
the scales independently. All control participants completed
the scales independently at home.
2.2.1. Dysarthria Impact Profile (DIP). Items from the origi-
nal questionnaire were translated into French by A.L. & S.P.
and compared with the original items by a bilingual linguis-
tics researcher. The final translated version integrated all the
translation adjustments. In the first 4 sections of the scale,
the person with PD was asked to rate statements in each
section using a five-point scale (“strongly agree,” “agree,” “not
sure,” “disagree,” and “strongly disagree”). In order to test the
responder reliability (i.e., the participant answer congruence
or responder consistency), the DIP scale incorporated 2
similar statements in each section, differently formulated.
The DIP uses positively and negatively worded statements. In
the positively worded statements, “strongly agrees” answers
receive a score of 5 and “strongly disagree” answers receive
a score of 1. Reversely, in negatively worded statement,
“strongly agrees” answers receive a score of 1 and “strongly
disagree” answers receive a score of 5. In the fifth section,
people were asked to list and rank (from 1 = most worry to
5 = least concern) their five main worries, including speech
impairment.TheDIP could be completed by the person him/
herself or with assistance. All answers were added to obtain a
global impact score; the lower the score, the higher the level
of impact.
2.2.2. Voice Handicap Index (VHI). TheVHI [3] is often con-
sidered as the gold standard for the evaluation of voice self-
perception [32]. It includes 30 items split into three domains:
physical, functional, and emotional. It has been previously
translated into French and validatedwith a Frenchpopulation
[33]. Each item is scored from 0 to 4 (“never,” “almost never,”
“sometimes,” “almost always,” and “always”); the higher the
score, the higher the degree of perceived handicap.
2.2.3. Parkinson’s Disease Questionnaire (PDQ-39). The
PDQ-39 [34] is a global and PD-specific quality of life
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Table 1: Demographics and characteristics of people with PD and control participants.
People with PDa Gender Age (years) Disease duration (years) UPDRS score on medication Controlsb Gender Age (years)
P1 Male 55 1.5 11 C1 Female 70
P2 Female 76 6.6 8 C2 Female 70
P3 Male 75 2.0 15 C3 Female 72
P4 Male 56 6.8 25 C4 Male 72
P5 Female 78 9.0 20 C5 Female 72
P6 Female 72 8.0 4 C6 Male 74
P7 Female 84 9.3 Missing data C7 Female 83
P8 Male 47 1.0 13 C8 Male 70
P9 Male 64 0.3 8 C9 Male 70
P10 Male 79 2.0 23 C10 Female 71
Mean ± SD 68.6 ± 12.3 4.7 ± 3.6 14.1 ± 7.2 72.4 ± 3.9
a
The selection criteria included patients diagnosed with idiopathic PD, no cognitive impairment, no history of hearing impairment, and no previous speech
therapy rehabilitation.The cognitive state of the patients was evaluated using either theMattisDementia Rating Scale [30] or theMini-Mental State Examination
[31]. None of the participants had any evidence of cognitive impairment. bNone of the control subjects had any history of hearing or cognitive impairment or
other neurologic or psychiatric disease.
questionnaire, also available in French [35].The scale consists
in 39 items allowing for the determination of an overall
quality-of-life score examining 8 specific domains: mobility,
activities of daily living, emotional well-being, stigma,
social support, cognition, communication, and bodily dis-
comfort. Each item is scored from 0 (normal) to 4 (maximum
disturbance); the higher the score, the higher the impairment
of quality of life.
2.3. Statistical Analyses. Statistical analyses (R Development
Core Team, http://www.r-project.org/) were carried out in
order to estimate the psychometric properties of the French
version of the DIP in our preliminary set of data. Since the
DIP scale is nominal, 𝜒2 test was used to evaluate the ability
of distinguishing people with PD from controls (discriminant
validity). Regarding the VHI, which is an ordinal scale,
Wilcoxon ranked test was performed. Internal consistency of
the DIP was assessed by calculating Cronbach’s 𝛼 coefficient
for each population. Responder reliability was tested by mea-
suring correlations between connected items within each of
the first 4 sections (Spearman’s 𝜌 coefficient). Concurrent
validity was assessed by correlating the DIP and VHI scores
(Spearman’s 𝜌 coefficient).
3. Results and Discussion
3.1. DIP Main Effects and Discriminant Validity. As it can be
seen in Table 2, the people with PD obtained lower scores
on the DIP than control subjects, suggesting a high level
of psychosocial impact of dysarthria in this population. The
French version of the DIP was able to discriminate between
control subjects and people with PD (𝜒2 = 176.6, df = 4,
𝑃 < 0.05), as did the VHI total score (Wilcoxon𝑊 = 78.5,
𝑃 < 0.05). In Section E of the DIP (“Dysarthria relative to
otherworries and concerns”), speechwas themain concern for
only 1 out of the 10 PD participants and an important worry
for 5 of them (50%).The remaining four people with PDwere
slightly or least concerned about their speech.
3.2. Internal Consistency. Internal consistency, (i.e., how well
all items in a scale correlate with each other and follow the
same trend) was assessed using Cronbach’s 𝛼 coefficient. An
adequate consistency is considered with a coefficient of at
least 0.70. Thus, internal consistency was confirmed for the
DIP total scores for both the PD (𝛼 = 0.93) and control (𝛼 =
0.76) populations. Internal consistencies were also confirmed
for the DIP subsections A (𝛼 = 0.85), B (𝛼 = 0.72), C
(𝛼 = 0.87), and D (𝛼 = 0.83) for the PD patients.
3.3. Responder Reliability. Responder reliability was tested by
measuring correlations between 2 connected items within
each subsection (Spearman’s 𝜌 correlation), sections A (“The
effect of dysarthria on me as a speaker”), B (“Accepting my
dysarthria”), and D (“How dysarthria affects my communica-
tion with others of the scale”) displayed statistically significant
correlations (𝜌 = 0.76, 𝜌 = 0.59, and 𝜌 = 0.72, resp., 𝑃 <
0.01), whereas the connected items of section C (“How I feel
others react to my speech”) did not show any correlation (𝜌 =
0.39, 𝑃 = 0.08).
3.4. Concurrent Validity of the DIP. Although the DIP, VHI,
and PDQ-39 levels of measurements are different (nominal
for the DIP, ordinal for the VHI and PDQ-39), we thought
important to have an idea of the construct validity by testing,
nevertheless, correlation analyses between the scales’ total
scores. As displayed in Figure 1, correlations between the DIP
and the VHI were high for both the people with PD and the
control subjects (Spearman’s 𝜌 = −0.70; 𝑃 < 0.01). Fur-
thermore, in the PD group, the total DIP score correlated
significantly with the “Functional” sub-section (the impact
of voice disorders on daily living activities) of the VHI scale
(𝜌 = −0.82, 𝑃 < 0.01).This was not the case with the PDQ-39
total score (𝜌 = −0.41, 𝑃 = 0.23).
3.5. Discussion Points. Due to the small number of partic-
ipants in the present study, our findings still have to be
considered as preliminary. Despite that fact, our data were
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Table 2: Total and mean scores from self-assessments.
People with PD DIPa (score/225) VHIb (score/120) PDQ-39b (score/156) Controls DIP VHI
P1 159 14 41 C1 166 69
P2 215 6 18 C2 189 5
P3 118 69 58 C3 200 9
P4 129 31 27 C4 192 13
P5 179 7 37 C5 201 5
P6 140 26 38 C6 204 17
P7 134 65 65 C7 190 1
P8 150 44 86 C8 197 8
P9 135 46 19 C9 203 10
P10 129 75 95 C10 199 13
Mean ± SD 148.8 ± 29.0 38.3 ± 25.6 48.4 ± 26.85 194.1 ± 11.1 15 ± 19.5
a
The lower the score, the higher the impact; bthe higher the score, the higher the impairment.
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Figure 1: Voice Handicap Index (VHI) versus Dysarthria Impact
Profile (DIP) total scores for the 20 participants (10 people with PD
and 10 control subjects).
able to demonstrate that (1) the French DIP was able to
discriminate people with PD from control subjects, (2) the
DIP was highly correlated with the VHI, and (3) no direct
relationship between the DIP and quality of life as assessed by
the PDQ-39 was displayed.This last point should be expected
as theDIP does not assess quality of life and the authors of the
DIP view quality of life and psychosocial impact as separate
constructs [19].
Speech and voice impairments are frequent in patients
with PD. PD speech manifesting itself most typically as a
hypokinetic dysarthria displays a combination of respiratory,
laryngeal, resonance, and supralaryngeal articulatory deficits
[36, 37]. Dysphonia in PD involves monotony of pitch
and loudness, a breathy and harsh voice, which represents
crucial parameters altering speech intelligibility and, as a
consequence, communication ability. This might account for
the strong correlation found between the DIP and VHI
scales.Methodological constraints did not allow us to acquire
neither any acoustical recordings nor any formal assessment
of the speech disorder severity. Further experiments will need
to take into account this aspect in order to explore the
relationship between the DIP and the severity of the speech
impairment. Moreover, this will be particularly of interest
when assessing different types of dysarthria, as carried out,
for example, regarding the validation of the French version of
the Speech Handicap Index [14].
The original DIP questionnaire was administered to
31 people with dysarthria, 10 of whom had PD [15]. We
performed the present exploratory study with the same
number of people with PD. In our group, the mean DIP
score was calculated to be 148.8 (cf. Table 2), which is similar
to that provided in the original study (144.9). Both English
and French versions of the DIP show good internal consis-
tency, arguing a reasonable similarity of our French version
with the original one. However, the lack of intraindividual
congruence of the 2-connected answers in section C we
found in the French version might result from the design
of the DIP, particularly the alternation between positive
and negative worded statements. In fact, this shift may
also imply difficulties for both patients and control subjects
when completing the scale, leading to possible incongruent
responses. This was not the case with the original version,
leading us to consider the need for some amendments in
the French version of the scale. Additionally, the completion
time of the DIP French version was rather long, more than
30 minutes on average for PD patients. Difficulties when
answering might also be due to the visual form of the
DIP. Changes are recommended in order to improve both
reading and recording responses and in order to shorten the
completion time for patients.These represent practical issues
that will be taken into account in a further amended format
of both English and French versions of the scale.Work on this
is currently underway.
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Some reliability and validity has been established with the
FrenchDIP used in the present experiment. However, further
validation needs to be performed in order to confirm the
psychometric properties demonstrated in our preliminary
results. To do so, the amended version of the French DIP
will need to be administered on a larger sample of people
with dysarthria, covering a range of different aetiologies. Due
to the fact that control subjects may also present with
speech alteration associated with age, as suggested by the
performance of one control (cf. Table 2 and Figure 1), a
larger number of controls covering a range of ages will also
be required. Test/reretest reliability and responsiveness to
change will have to be considered as well. Work on these
aspects is underway in the English version. Regarding spe-
cifically the French version, a back-to-back translation proce-
dure should be planned for the updated version of the scale.
4. Conclusions
While some behavioural treatments for speech in PD might
have predictable beneficial impacts [38], pharmacological
and/or neurosurgical treatments have relatively limited and
variable effects on PD speech [39].There is a need to consider
treatments beyond the level of impairment thereby justifying
the use of a self-administered questionnaire to measure the
psychosocial impact of dysarthria from the perspective of
the speaker. This is particularly of interest since this kind
of self-assessment may help the patient realise his/her dif-
ficulties and lead him/her to take part with the clinician in
therapeutic work. The DIP is part of a range of new self-
assessments, including the Speech Handicap Index [12, 14]
and the French Parole Handicap Index [13], all aiming at
producing “a comprehensive picture of speech impairment”
[14]. Our preliminary data suggest that the French version of
the DIPmay have the potential to make a useful contribution
to outcome management in acquired dysarthria for both
clinicians and researchers.
Availability of the French Version of the DIP
In order to obtain a copy of the French version of the DIP
used in the present study, interested parties should contact
the corresponding author (serge.pinto@lpl-aix.fr) whowill be
pleased to send a copy of the material.
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